FARXIGA is one small prescription pill that can be used:
- To reduce the risk of further worsening of your kidney disease, end-stage kidney disease (ESKD), death due to cardiovascular disease, and hospitalization for heart failure in adults with chronic kidney disease
- To reduce the risk of cardiovascular death, hospitalization for heart failure and urgent heart failure visit in adults with heart failure, when the heart cannot pump enough blood to the rest of your body
- To reduce the risk of hospitalization for heart failure in adults with type 2 diabetes who also have known cardiovascular disease or multiple cardiovascular risk factors
- Along with diet and exercise to improve blood sugar (glucose) control in adults and children who are 10 years of age or older with type 2 diabetes
FARXIGA is not for use to improve blood sugar (glucose) control in people with type 1 diabetes.
FARXIGA is not for use to improve blood sugar (glucose) control in people with type 2 diabetes who have moderate to severe kidney problems, because it may not work.
FARXIGA is not for people with certain genetic forms of polycystic kidney disease, or who are taking or have recently received immunosuppressive therapy to treat kidney disease. FARXIGA is not expected to work if you have these conditions.
It is not known if FARXIGA is safe and effective to lower blood sugar (glucose) in children younger than 10 years of age with type 2 diabetes.
It is not known if FARXIGA is safe and effective for treatment of heart failure or chronic kidney disease in children younger than 18 years of age.